Envest Ventures III

Envest is a Virginia-based private equity firm that specializes in early-stage investments across various basic industries in the eastern United States, including healthcare, manufacturing, franchising, business services, and non-revolutionary technologies. Established in 1999, Envest has a strong track record, achieving top decile performance among its peers in private equity. The firm's principals possess extensive experience in managing both large and small businesses, which they leverage to provide not only capital but also strategic direction and governance to their portfolio companies. Envest aims to support the growth and development of businesses in its target sectors, fostering innovation and operational improvements.

John Garel

Founder

David Kaufman

Co-Founder

Patrick Keefe

Managing Director

John Reed

Managing Director

7 past transactions

Eywa Pharma

Venture Round in 2016
Eywa Pharma is a global generic pharmaceutical company established by experienced professionals from the pharmaceutical industry. The company focuses on manufacturing a wide range of generic medications, ensuring continuous access to essential medicines. Its product offerings span various therapeutic areas and dosage forms, including tablets, capsules, and oral suspensions. Eywa Pharma achieves its goals through a combination of in-house development and strategic in-licensing, enabling it to provide effective and affordable medications to patients and healthcare systems.

NuScriptRx

Series D in 2014
NuScriptRX, Inc. operates a long-term care pharmacy store. The company engages in delivering medications to long-term care facilities. NuScriptRX, Inc. was formerly known as New Day Pharmacy Corporation. The company was incorporated in 2004 and is based in Nashville, Tennessee.

Xan3D Technologies

Series C in 2004
Xan3D Technologies is a semiconductors manufacturer that uses hybrid integrated circuit technology to produce semiconductors for the data communications, telecommunications, and computing industries. By utilizing the optically integrated electronic circuit technology, Xan3D Technologies designs and manufactures optical connection products for next generation data links and optical communication applications. Xan3D Technologies offers flexible networking and processing solutions for data communications, telecommunications, and computing markets. It is headquartered in Merrimack, New Hampshire.

Inspiris

Series D in 2004
UnitedHealthcare Community Plan can help you find a Medicaid or Medicare plan that best fits your needs. Find benefits, eligibility & detailed plan information.

Xan3D Technologies

Series B in 2002
Xan3D Technologies is a semiconductors manufacturer that uses hybrid integrated circuit technology to produce semiconductors for the data communications, telecommunications, and computing industries. By utilizing the optically integrated electronic circuit technology, Xan3D Technologies designs and manufactures optical connection products for next generation data links and optical communication applications. Xan3D Technologies offers flexible networking and processing solutions for data communications, telecommunications, and computing markets. It is headquartered in Merrimack, New Hampshire.

TriVirix International

Series C in 2001
TriVirix International is a U.S.-based company that manufactures and designs electro-mechanical, medical, diagnostic, analytical, and life-science devices. The company provides its clients with ribo printers, point-of-care blood testing analyzers, volumetric infusion pumps, and vital sign or conscious sedation monitors. TriVirix International is headquartered in Milaca, Minnesota.

IntervalZero

Venture Round in 2000
IntervalZero’s RTX software transforms Windows into a Real-Time Operating System (RTOS). For projects that demand a Windows user experience and require hard real-time or determinism, the RTX RTOS Platform enables OEMs and end users to capitalize on Windows, x86 multi-core multi-processor technology , symmetric multiprocessing (SMP) and real-time Ethernet. The RTX RTOS Platform reduce reliance on proprietary hardware such as DSPs and MCUs RTX has achieved a Safety Integrity Level 3 – SIL-3 – certifications and FDA Class II certification with numerous medical equipment manufacturers.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.